Virtus LifeSci Biotech Clinical Trials ETF BBC
Set alert
43.05 USD -0.85 -1.94%
At close · Oct 30
43.05 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
42.38 Day range 43.71
28.73 52-week range 56.18
- YTD
- +11.64%
- 1 year
- +34.36%
- Open
- 43.71
- Prev close
- 43.90
- Mkt cap
- 34.44M
- Vol
- 10.76K
- Avg vol
- 23.55K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 42.38
- High
- 43.71
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 27.91
- 200-d avg
- 27.48
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 27.91
- 200-day average
- 27.48
About Virtus LifeSci Biotech Clinical Trials ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
News
Your note
Sign in to keep a note on BBC — it syncs with the Stock Master app.